Passage Bio Inc (NAS:PASG)
$ 0.657 -0.0029 (-0.44%) Market Cap: 40.58 Mil Enterprise Value: -18.43 Mil PE Ratio: 0 PB Ratio: 0.56 GF Score: 36/100

Passage Bio Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 10:20PM GMT
Release Date Price: $1.02 (+6.14%)
Unidentified Analyst

All right. Thanks, everyone, for joining us here at the Goldman Sachs Global Healthcare Conference day 1. So really excited to be joined by Mike from Passage Bio to walk -- oh, for Christ's...

William Chou
Passage Bio, Inc. - President, CEO & Director

That's all right. Like I said, you're busy today.

Unidentified Analyst

So Will from Passage. We're excited to hear about Passage's progress and kind -- I just think, interesting transition coming in the next year or so. So some factor disclosures, we're required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We're prepared to read a lot of disclosures for any issuer during the sessions upon your request. However, these disclosures are available in our most recent reports available to you as clients on our firm's portal.

In addition, updates to those disclosures are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot